Home / People / Dr. Jens Wagner
Portrait of Jens Wagner

Dr. Jens Wagner

Rechtsanwalt | Co-Head of the CMS Life Sciences & Healthcare Group

CMS Hasche Sigle
Stadthausbrücke 1-3
20355 Hamburg
Languages German, English

With long-standing experience in the pharmaceutical, biotech, medical device and food supplements sectors, Jens Wagner provides comprehensive advisory and litigation services to life science companies. He also assists companies in various industries with IP matters. Alongside trademark, patent and licensing cases, his clients regularly instruct him with regulatory and compliance mandates. Business development transactions and agreements as well as liability and IP litigation are also important practice areas.

Jens joined one of the CMS predecessor firms in 1994 and has been a CMS partner since 1998. He worked with Thacher, Albrecht & Ratcliffe in San Francisco in 1993 and was seconded to CMS in London in 2000.

more less

"preeminent expertise in international contractual matters", competitor

JUVE German Commercial Law Firms 2021 (GCLF)

"Recommended" for Pharmaceuticals and Healthcare, Trademarks and Unfair Competition

JUVE German Commercial Law Firms 2021 (GCLF)

"extremely skilled in international contexts"

JUVE German Commercial Law Firms 2015 (GCLF)

"hard yet likeable opponent" (competitor)

JUVE German Commercial Law Firms 2015 (GCLF)

„ist ‘lösungsorientiert und berücksichtigt wirtschaftliche Zielsetzungen und Aspekte’“

The Legal 500 Deutschland, 2014/2015

"He is described as ‘very solution-oriented’ and is recommended for his ‘around-the-clock availability and responsiveness’."

Chambers Europe 2015

"opponent to be taken seriously, very personable"

JUVE German Commercial Law Firms 2014 (GCLF)

"rare combination of competence, unpretentious demeanor and excellent collaboration" (competitors)

JUVE German Commercial Law Firms 2014 (GCLF)

Memberships & Roles

  • German Association for the Protection of Intellectual Property (GRUR)
  • Guest member of GRUR’s expert committee for pharmaceutical and food law
more less


  • Pick and mix - Choosing between European and German customs actions, Copyright World 2006, p. 15 ff
more less


  • 1995: PhD (Dr. jur.)
  • 1994: Admitted as a lawyer
  • Law studies in Hanover and Hamburg
  • Trained as a banker
more less


Vac­cine com­pens­a­tion re­gimes in Ger­many
1. Are COV­ID-19 vac­cin­a­tions ob­lig­at­ory in your jur­is­dic­tion? Are you ex­pect­ing any le­gis­lat­ive changes to en­able man­dat­ory vac­cines for all or cer­tain people (e.g. health­care pro­fes­sion­als, pub­lic ser­vants...
CMS Life Sci­ences & Health­care Glob­al Bro­chure
With big deals fuel­ling re­cord levels of M&A activ­ity, a steady stream of in­nov­at­ive and dis­rupt­ive tech­no­lo­gies, new and in­creas­ingly com­plex reg­u­lat­ory chal­lenges and a thriv­ing start-up com­munity...
On the Pulse
Wel­come to CMS ‘On the Pulse’ video/pod­cast series for all Life Sci­ences & Health­care law­yers
Phar­ma­ceut­ic­al ad­vert­ising reg­u­la­tion and med­ic­al device ad­vert­ising in...
1. Which laws are ap­plic­able re­gard­ing ad­vert­ising of medi­cines and med­ic­al devices? The ad­vert­ising of medi­cines and med­ic­al devices is gov­erned by the Law on Ad­vert­ising in the Health Sec­tor (Heilmit­tel­wer­bege­setz...
Glob­al Di­git­al Health Fest­iv­al 2020 – Vir­tu­al – High­lights
The in­aug­ur­al ‘Glob­al Di­git­al Health Fest­iv­al – Vir­tu­al’ brought to­geth­er in­dustry ex­perts and CMS sec­tor spe­cial­ists over four days (23-26 Novem­ber 2020) to ana­lyse and dis­cuss the role that tech­no­logy...
Glob­al Di­git­al Health Fest­iv­al - Vir­tu­al: Di­git­al trends trans­form­ing HealthTech
Join us for our in­aug­ur­al Glob­al Di­git­al Health Fest­iv­al - Vir­tu­al from 23-26 Novem­ber.   Day 1: Is AI still the fu­ture of health­care? No, it’s the present. But can we keep up with it?Con­sid­er­a­tion...
Fu­ture fa­cing life sci­ence and health­care: A wealth of op­por­tun­it­ies, an...
 Pa­tient-cent­ric in­nov­a­tion in the life sci­ence and health­care sec­tors – that was the over­arch­ing theme of this year's CMS Glob­al Life Sci­ence and Health­care For­um, held in Frank­furt on 21 Novem­ber...
CMS Glob­al Life Sci­ences & Health­care For­um 2019
 We have the pleas­ure to cor­di­ally in­vite you to our    on Thursday, 21 Novem­ber 2019, at 09:30 CET in Frank­furt.The For­um will provide in­sights from ex­tern­al ex­perts and CMS spe­cial­ists on four core...
An­nu­al Re­view 2018 – 2019
Cross­ing bor­ders is both the theme of this year’s CMS An­nu­al Re­view and a guid­ing idea that we had when we es­tab­lished CMS 20 years ago. At that time, we de­cided to cre­ate a high-qual­ity, ex­pert and mul­tijur­is­dic­tion­al law firm. This Re­view shows what we’ve achieved over the last year in pur­suit of this goal.Since 1999, work­ing across bor­ders has be­come a daily task for all our law­yers. We are one of the most in­ter­na­tion­al law firms, with more than 70 of­fices in over 40 coun­tries. Our 4,800 leg­al ex­perts world­wide work as one team across jur­is­dic­tions, prac­tice areas and sec­tors to en­sure that you get clear, ac­tion­able and busi­ness-fo­cused ad­vice. You can read about our mul­tijur­is­dic­tion­al sup­port for cli­ents in the stor­ies through­out this An­nu­al Re­view. For ex­ample: an in­ter­na­tion­al CMS team ad­vised Ad­vance / Ne­w­house Part­ner­ship on its pur­chase of Stage En­ter­tain­ment, one of the world’s largest theatre pro­du­cers and own­ers. Our law­yers spe­cial­ising in cor­por­ate, me­dia, real es­tate, tax, em­ploy­ment, IP, com­pet­i­tion and bank­ing all worked on the trans­ac­tion.Glob­al­isa­tion con­tin­ues to im­pact the busi­ness en­vir­on­ment pro­foundly, as do the key is­sues on the glob­al agenda such as the US trade talks with China, Brexit and the con­sequences of cli­mate change. With our glob­al firm struc­ture and mind­set, we help you an­ti­cip­ate the prob­lems you face in your daily op­er­a­tions. On page 28, you can read what some of our part­ners around the world have told us about the chal­lenges their cli­ents are cur­rently fa­cing.An­oth­er ma­jor factor shap­ing our daily work is the im­pact of tech­no­logy on all busi­nesses. This year, our an­nu­al event in Da­v­os on the oc­ca­sion of the World Eco­nom­ic For­um (see page 18) fo­cused on how in­creased di­git­al­isa­tion is af­fect­ing con­ven­tion­al busi­ness mod­els.Today, in­tro­du­cing more ad­vanced tech­no­lo­gic­al tools in­to leg­al prac­tice is a must in or­der to meet cli­ents’ qual­ity and ef­fi­ciency ex­pect­a­tions. For CMS, it is about more than just us­ing ar­ti­fi­cial in­tel­li­gence soft­ware or di­git­al tools. To us, in­nov­a­tion means de­vel­op­ing tech­no­logy to of­fer our cli­ents new high-qual­ity ser­vices and to provide new ways of de­liv­er­ing all our leg­al of­fer­ings. Our scale and pres­ence across many jur­is­dic­tions, coupled with our deep un­der­stand­ing of cli­ent needs in their loc­a­tions, means that we are very well qual­i­fied to de­vise such solu­tions. On page 16, some of our key in­nov­at­ors de­scribe the ways in which our tech­no­logy is be­ne­fit­ting cli­ents.I hope you find some in­ter­est­ing and thought-pro­vok­ing stor­ies in this year’s An­nu­al Re­view and wish you an en­joy­able read. My col­leagues in the CMS ex­ec­ut­ive team and I are al­ways happy to hear from you if you have any com­ments or ques­tions.Cor­neli­us Brandi, Ex­ec­ut­ive Chair­man
CMS Life Sci­ences & Health­care Sec­tor Group: An over­view of our Asia-Pa­cific,...
CMS has a truly glob­al Life Sci­ences & Health­care Sec­tor Group with over 300 law­yers and pat­ent at­tor­neys fo­cused on the sec­tor. Out­side of Europe, we are rap­idly grow­ing as a group and have teams in...
CMS Glob­al Life Sci­ences & Health­care For­um
The event will take place on Thursday, 22 Novem­ber 2018 at the Volk­shaus in Basel, Switzer­land.A re­cep­tion on the top floor of the Messe Tower will be part of the pro­gram.The for­um will con­tain present­a­tions...
CMS Glob­al Lifes­ci­ences For­um 2017
The Lifes­ci­ences in­dustry is de­vel­op­ing rap­idly – not only from a busi­ness per­spect­ive, but also with re­gard to the leg­al en­vir­on­ment. New reg­u­la­tions, new case law and new busi­ness mod­els pose key...